
Digitalisation
FIWARE FINODEX
FIWARE FINODEX (Future Internet Open Data Expansion) is a European business incubator and accelerator.
Polycystic Ovary Syndrome (PCOS) In Adolescent Girls And Young Women: Toward A Treatment Guided By Pathophysiology
Project dates
2021 - 2026
Website
Role of Zabala
Partner
Project led by
Fundació Sant Joan de Déu
17
Partners
9
Countries
6 M€
Total budget
5
Years
Polycystic Ovary Syndrome (PCOS) is the most prevalent, chronic, endocrine-metabolic disorder in women of reproductive age, affecting 5-10% of women worldwide. It is the most frequent cause of anovulatory subfertility, and it is also associated with lifelong co-morbidities such as type 2 diabetes, premature vascular aging, premenopausal cancer and anxiety or depression.
There is currently no approved treatment for PCOS in adolescent and young women, approximately 98% of whom are prescribed oral contraceptives (OCs) off-label. OCs do alleviate key symptoms, such hirsutism and menstrual irregularity, but do not revert the underlying pathophysiology, and patients remain at risk for post-treatment subfertility.
Previous studies by FSJD and Katholieke Universiteit Leuven have led to the identification of a treatment, (SPIOMET) that consists of two “insulin sensitisers” (pioglitazone [PIO] and metformin [MET]) and a mixed anti-androgen and anti-mineralocorticoid (spironolactone [SPI]), which also acts as a brown adipose tissue activator. However, these studies had some limitations that SPIOMET4HEALTH aims to overcome. The project will test a novel treatment of SPIOMET in a single tablet (SPI, 50 mg; PIO, 7.5 mg and MET, 850 mg) administered daily, in combination with certain lifestyle measures. It aims at normalising ovulation and endocrine-metabolic status through reduction of hepato-visceral fat excess.
SPIOMET4Health could change the current paradigm of PCOS treatment, as the new therapy will not only target the gonadotropic axis, but also the underlying pathophysiology. This strategy should also reduce the psychosocial impact and economic burden of PCOS on healthcare systems. SPIOMET4HEALTH can also become a preconception strategy to be followed by spontaneous ovulation/conception, normal pregnancy and a healthier next generation.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme, under grant agreement No. 899671.
“SPIOMET4Health is proposed by a consortium of the highest-profile groups working on PCOS in adolescent girls and young adults (AYAs); this project offers the EU a unique opportunity to enable a robust attempt to generate medical benefits for patients with PCOS.”
Laura Sesma
Health Knowledge Area Leader
Digitalisation
FIWARE FINODEX (Future Internet Open Data Expansion) is a European business incubator and accelerator.
Digitalisation
Creation of an IHL federation for the large-scale adoption of digital technologies for European SMEs
Health, Agri-food and Bioeconomy
The main objective of Ves4us is to generate a wide range of radically new, high-value products in the fields of...
News
ETIP SNET AND BRIDGE
Opinion
ENERGY STORAGE
Alessandro Provaggi
Head of Brussels office
Publication
LIFE 2021-2027
Don't miss the changes in administrative and financial management that have taken place in LIFE, the most important European environmental programme
The important thing is not to keep moving, but rather to know in which direction to go. Our 37% success rate proves that we know how to guide our clients.
Our compass is our clients; our mission is to solve their problems, guiding them so that innovation becomes their key to competitiveness.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
This website uses the following additional cookies:
(List the cookies that you are using on the website here.)
Please enable Strictly Necessary Cookies first so that we can save your preferences!